HEMOLYTIC-UREMIC SYNDROME DUE TO DEOXYCOFORMYCIN - A REPORT OF THE 2ND CASE

被引:19
作者
SAKAI, C
TAKAGI, T
WAKATSUKI, S
MATSUZAKI, O
机构
[1] Division of the Hematology and Chemotherapy, Chiba Cancer Center Hospital, Chiba
[2] Division of Surgical Pathology, Chiba Cancer Center Hospital, Chiba
关键词
ADULT T-CELL LEUKEMIA; MICROANGIOPATHIC HEMOLYTIC ANEMIA; RENAL FAILURE; HYPERTENSION;
D O I
10.2169/internalmedicine.34.593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A hypercalcemic patient with adult T-cell leukemia was treated with deoxycoformycin (DCF) in a dose of 5 mg/m(2) daily for three days, Several days later, severe thrombocytopenia appeared abruptly and then microangiopathic hemolytic anemia ensued, Subsequently, renal failure and hypertension developed, and the patient died seven weeks after DCF therapy, Needle necropsy of the kidney showed glomerular damage including swelling of endothelial cells, mesangiolysis and segmental collapse, This is the second reported case of hemolytic-uremic syndrome due to DCF.
引用
收藏
页码:593 / 596
页数:4
相关论文
共 23 条
[1]  
Neil G., Haemolytic-uraemic syndrome in practice, Lancet, 343, (1994)
[2]  
Beattie T.J., Recent developments in the pathogenesis of hemolytic uremic syndrome, Renal Failure, 12, (1990)
[3]  
Kressel B.R., Ryan K.P., Duong A.T., Berenberg J., Schein P.S., Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma, Cancer, 48, (1981)
[4]  
Jackson A.M., Rose B.D., Graff L.G., Et al., Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy, Ann Intern Med, 101, (1984)
[5]  
Murgo A.J., Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents, Semin Hematol, 24, (1987)
[6]  
Gardner G., Mesler D., Gitelman H.I., Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: A report of a case and a review of the literature, Renal Failure, 11, (1989)
[7]  
Grem J.L., Merritt J.A., Carbone P.P., Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine, Arch Intern Med, 146, (1986)
[8]  
Dillman R.O., A new chemotherapeutic agent: deoxycoformycin (pentostatin), Semin Hematol, 31, (1994)
[9]  
Spiers A.S.D., Moore D., Cassileth P.A., Et al., Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin), N Engl J Med, 316, (1987)
[10]  
Dillman R.O., Yu A., Qiao C.N., Repeated pentostatin (2′-deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia, West J Med, 148, (1988)